Dec 31, 2021

Xenon Pharmaceuticals Q4 2021 Earnings Report

Total Revenue
$3.74M
Previous year: $5.15M
-27.4%
EPS
-$0.48
Previous year: -$0.34
+41.2%
Gross Profit
-$18.2M
Previous year: -$9.82M
+84.9%
Cash and Equivalents
$176M
Previous year: $45M
+290.3%
Free Cash Flow
-$21.2M
Previous year: -$13.9M
+52.2%
Total Assets
$572M
Previous year: $189M
+202.4%

Xenon Pharmaceuticals

Xenon Pharmaceuticals